Inactive Instrument

Insiders Caladrius Biosciences Inc Nasdaq

Equities

US1280581042

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Apr. 23	Lisata Therapeutics, Qilu Pharmaceutical Dose First Patient in China Trial of LSTA1 Plus Chemo for Pancreatic Cancer	MT
Apr. 23	Lisata Therapeutics, Inc and Qilu Pharmaceutical Co., Ltd Announce First Patient Treated in Qilu?s Phase 2 Trial in China of LSTA1 in Patients with Metastatic Pancreatic Ductal Adenocarcinoma	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lisata Therapeutics, Inc. Appoints James Nisco as Senior Vice President, Finance and Treasury and Chief Accounting Officer	Apr. 17	CI
Lisata Therapeutics, Inc. Announces Retirement of Erkki Ruoslahti from Board of Directors	23-07-11	CI
Lisata Therapeutics Announces Resignation of David Slack as President and Chief Business Officer	23-05-01	CI
Caladrius Biosciences, Inc. Announces Management Changes	22-09-15	CI
Caladrius Biosciences, Inc. has Changed its Name to Lisata Therapeutics, Inc	22-09-13	CI
Todd C. Girolamo Intent to Resign as Chief Legal Officer, Senior Vice President of Corporate Development and Corporate Secretary of Caladrius Biosciences, Inc., Effective March 14, 2022	22-02-25	CI
Caladrius Biosciences Announces Appointment of Kristen K. Buck as Chief Medical Officer	21-09-01	CI
Caladrius Biosciences, Inc. Announces Executive Changes	20-11-17	CI
Caladrius Biosciences, Inc. Appoints Anne Whitaker to Board of Directors	20-11-02	CI
Caladrius Biosciences, Inc. Announces Resignation of Joseph Talamo as Senior Vice President	20-08-05	CI
Caladrius Biosciences Announces the Resignation of Joseph Talamo, Chief Financial Officer	20-08-05	CI
Caladrius Biosciences, Inc. Appoints Dr. Michael H. Davidson to Board of Directors	20-07-28	CI
Caladrius Biosciences, Inc. Announces the Appointment of Ms. Cynthia Schwalm to Its Board of Directors	18-11-08	CI
Caladrius Biosciences Announces Addition of Four Clinical Sites; Announces Executive Appointments	17-04-03	CI
Caladrius Biosciences, Inc. Announces Board Changes	17-03-30	CI
Caladrius Biosciences, Inc. Announces Resignation of Andrew Pecora as Director	16-12-30	CI
Caladrius Biosciences Appoints Gregory R. Brown to its Board of Directors	16-10-12	CI
Caladrius Biosciences, Inc. Names Robert A. Preti as Chairman of the Alliance for Regenerative Medicine	16-06-27	CI
Caladrius Announces Changes to its Board of Directors	15-12-23	CI
Caladrius Biosciences, Inc. Announces Management Changes	15-10-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Caladrius Biosciences Inc Nasdaq

Equities

US1280581042

Insiders

Filters